Who's to blame as Moderna's stock falls amid slashed guidance?
Aug 1, 2024 · Moderna shares slid more than 20% Thursday after the company slashed its sales guidance for 2024, largely because of a lack of new COVID-19 vaccine orders from the …
OFF
Who's To Blame As Moderna's Stock Falls Amid Slashed Guidance?
3 weeks from now
Aug 1, 2024 · Moderna shares slid more than 20% Thursday after the company slashed its sales guidance for 2024, largely because of a lack of new COVID-19 vaccine orders from the …
yahoo.com
OFF
Moderna's Revenue Warning Sends The Stock Into The Red For 2024
3 weeks from now
Aug 1, 2024 · The company now expects full-year product revenue of $3 billion to $3.5 billion, down from its earlier estimate of $4 billion. Moderna cited “very low [European Union] sales in …
allsides.com
OFF
Moderna Cuts 2024 Sales Forecast, Sees Low EU Vaccine Revenue …
3 weeks from now
Aug 1, 2024 · The vaccine maker's shares plunged more than 15% to $101.01, taking the company's market value to $38.71 billion. It had peaked at nearly $200 billion at the height of …
usnews.com
OFF
Moderna Inc (MRNA) Q3 2024 Earnings Call Highlights: Strong …
3 weeks from now
Nov 8, 2024 · Moderna Inc (MRNA) reports $1.9 billion in revenue and outlines future growth strategies despite competitive pressures and legal challenges.
yahoo.com
OFF
Moderna Takes Axe To '24 Sales Guidance, Sending Shares Lower
3 weeks from now
Aug 1, 2024 · But these forecasting challenges are still dragging on into 2024. Take Moderna, which just chopped $500 million to $1 billion from its 2024 sales forecast—in August—leaving …
fiercepharma.com
OFF
Moderna's Stock Pops After Biotech Ekes Out A Surprise Profit, And ...
3 weeks from now
Nov 7, 2024 · The FactSet consensus was for a loss of $1.94 on revenue of $1.3 billion. "Looking into the fourth quarter and preparing for 2025, we remain focused on driving sales growth, …
morningstar.com
OFF
Moderna's $1 Billion Revenue Forecast Cut Sends Stock
3 weeks from now
Jan 13, 2025 · Moderna shares tumbled Monday after the company cut its 2025 revenue forecast by $1 billion. The company expects much of its revenue to be realized in the back half of the …
investopedia.com
OFF
Moderna Reports Surprise Profit On Higher-Than-Expected ... - U.S.
3 weeks from now
Nov 7, 2024 · Moderna still expects to make less from COVID vaccine sales this year than it did in 2023, however, and reaffirmed its 2024 sales forecast of $3 billion to $3.5 billion. The …
usnews.com
OFF
Moderna Stock Breaks Out For The First Time In A Year After Covid …
3 weeks from now
May 2, 2024 · That will be weighted to the back half of the year with less than $300 million in sales projected for the first half of 2024. Moderna stock analysts project $4.19 billion in full …
investors.com
OFF
Here's What To Expect From Moderna's Next Earnings Report
3 weeks from now
4 days ago · The company’s revenue of $1.86 billion surpassed Wall Street expectations of $1.26 billion, a 1.7% increase year-over-year. Moderna has reiterated its 2024 net product sales …
nasdaq.com
OFF
Moderna’s Recent Drop: 4 Reasons Bulls See Opportunity
3 weeks from now
Sep 16, 2024 · The medical sector company lost $1.3 billion on revenue of just $241 million in its second quarter of 2024. Moderna announced on its R&D Day plans to trim its R&D budget by …
nasdaq.com
OFF
Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand …
3 weeks from now
Nov 8, 2024 · On Thursday, Moderna Inc. (NASDAQ:MRNA) reported third-quarter revenue of $1.83 billion, beating the consensus of $1.25 billion. The company attributed the growth to …
yahoo.com
OFF
After Moderna's Shocking News, Is The Stock A Buy Or A Sell?
3 weeks from now
Sep 14, 2024 · Moderna's (MRNA-9.39%) struggles may last a little longer than expected. The biotech company had seen both sales and its stock price plummet as demand for its …
fool.com
OFF
Mixed Signals From Moderna’s Q3 2024 Performance ... - Markets …
3 weeks from now
Nov 7, 2024 · In another report released on October 28, Evercore ISI also maintained a Hold rating on the stock with a $60.00 price target. See the top stocks recommended by analysts >>
businessinsider.com
OFF
Moderna: Optimistic Outlook Despite The Recent Sell-Off
3 weeks from now
Nov 26, 2024 · The company reaffirmed its revenue guidance of $3-3.5 billion for 2024, which, taking into account the 9M2024 revenue, implies the 4Q24 revenue of $0.8-1.3 billion.
seekingalpha.com
OFF
Moderna Stock Jumps On Surprise Profit After Earnings Beat
3 weeks from now
Vaccine maker Moderna reports a profit of 55 cents a share on revenue of $2.8 billion in the fourth quarter, beating analysts’ expectations.
barrons.com
OFF
Moderna Posts Surprise Profit As Covid Vaccine Sales ... - NBC New …
3 weeks from now
Nov 7, 2024 · The company reiterated its full-year 2024 product sales guidance of roughly $3 billion to $3.5 billion. ... for deferred international revenue into 2025. ... News 24/7 Send a …
nbcnewyork.com
OFF
Moderna Is Expecting Massive Growth Over The Next Decade. Is …
3 weeks from now
Sep 22, 2023 · Between 2024 and 2028, the company plans to spend $25 billion on research and development (R&D). This year alone, the company expects to spend $4.5 billion on R&D with …
fool.com
OFF
Moderna Stock Slashes Hefty Premarket Gain With A Beat That's …
3 weeks from now
Nov 7, 2024 · Moderna stock closed down 2.9% at 50.29. That pulled back from a bigger 9.4% gain in earlier action. Moderna stock has a poor IBD Digital Relative Strength Rating of 5. This …
investors.com
FAQs about Who's to blame as Moderna's stock falls amid slashed guidance? Coupon?
Why did Moderna stock drop 2024?
How much will Moderna sell in 2024?
Why did Moderna share price drop Monday?
How much revenue will Moderna expect in 2027?
How did Moderna's third-quarter revenue perform?
Why did Moderna cut its sales guidance?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
